These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38022178)

  • 1. Evaluation of Weight-Based Co-trimoxazole Dosing in a Saudi Tertiary Hospital.
    Alshehri S; Alghuraybi R; Ayoub E; Bokhary J; Lashkar M; Alshibani M; Eljaaly K
    Cureus; 2023 Oct; 15(10):e47400. PubMed ID: 38022178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the Efflux Pumps SmeVWX and SmeDEF Is a Major Cause of Resistance to Co-trimoxazole in Stenotrophomonas maltophilia.
    Sánchez MB; Martínez JL
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK paediatric oncology
    Proudfoot RH; Phillips B
    Arch Dis Child; 2021 Oct; 106(10):994-998. PubMed ID: 33632786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-COVID-19
    Niamatullah H; Nasir N; Jabeen K; Rattani S; Farooqi J; Ghanchi N; Irfan M
    Access Microbiol; 2023; 5(1):acmi000406. PubMed ID: 36860506
    [No Abstract]   [Full Text] [Related]  

  • 5. Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis.
    Matraiah EH; Olisaka N; Philipos M; Walbaum D; Dospinescu P; Fluck N; Basu N; Kidder D
    Clin Rheumatol; 2018 Jul; 37(7):1991-1996. PubMed ID: 29808456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal Inhibitory Concentration of Ceftazidime and Co-trimoxazole for Stenotrophomonas Maltophilia using E-test.
    Jamali F; Boroumand MA; Yazdani F; Anvari MS; Pourgholi L; Mahfouzi S; Khak M
    J Glob Infect Dis; 2011 Jul; 3(3):254-8. PubMed ID: 21887057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
    Yang P; Zhu X; Liang W; Cai R
    Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study.
    Mendelson F; Griesel R; Tiffin N; Rangaka M; Boulle A; Mendelson M; Maartens G
    BMC Infect Dis; 2018 Aug; 18(1):399. PubMed ID: 30107791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation.
    Zou J; Wang T; Qiu T; Zhou J; Chen Z; Ma X; Jin Z; Xu Y; Zhang L
    Transpl Immunol; 2022 Jun; 72():101593. PubMed ID: 35367619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab.
    Park JW; Curtis JR; Jun KI; Kim TM; Heo DS; Ha J; Suh KS; Lee KW; Lee H; Yang J; Kim MJ; Choi Y; Lee EB
    Chest; 2022 May; 161(5):1201-1210. PubMed ID: 34788668
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Almaghrabi RS; Alfuraih S; Alohaly R; Mohammed S; Alrajhi AA; Omrani AS
    Tanaffos; 2019 Mar; 18(3):238-243. PubMed ID: 32411264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Activities of Antimicrobials Against
    Boonmee P; Nasomsong W; Lorchirachoonkul N; Pungcharoenkijkul S; Juntanawiwat P; Chaemchaeng S; Santimaleeworagun W
    Infect Drug Resist; 2023; 16():5173-5184. PubMed ID: 37581163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to trimethoprim/sulfamethoxazole initiation among patients with rheumatic disease complicated by Pneumocystis jirovecii pneumonia: impact on 90-day mortality.
    Song S; Zhang Y; Yu J; Xie C; Chen Y; Zhang X
    BMC Infect Dis; 2022 Dec; 22(1):961. PubMed ID: 36575406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study.
    Gaborit BJ; Tessoulin B; Lavergne RA; Morio F; Sagan C; Canet E; Lecomte R; Leturnier P; Deschanvres C; Khatchatourian L; Asseray N; Garret C; Vourch M; Marest D; Raffi F; Boutoille D; Reignier J
    Ann Intensive Care; 2019 Nov; 9(1):131. PubMed ID: 31776705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of and risk factors for Pneumocystis jirovecii pneumonia in anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody-positive dermatomyositis patients: a single-center retrospective study.
    Li J; Wang S; Zheng J; Li Q; Li J; Lu L
    Clin Rheumatol; 2023 Feb; 42(2):453-462. PubMed ID: 36301369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR.
    Huang Y; Yi J; Song JJ; Du LJ; Li XM; Cheng LL; Yan SX; Li HL; Liu YM; Zhan HT; Dou YL; Li YZ
    Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):102. PubMed ID: 37986091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for
    Awad M; Sierra CM; Mesghali E; Bahjri K
    J Oncol Pharm Pract; 2021 Dec; 27(8):1936-1939. PubMed ID: 33307970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.
    Falagas ME; Valkimadi PE; Huang YT; Matthaiou DK; Hsueh PR
    J Antimicrob Chemother; 2008 Nov; 62(5):889-94. PubMed ID: 18662945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.